These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 18525266)

  • 1. Marked increase in the incidence of invasive anal cancer among HIV-infected patients despite treatment with combination antiretroviral therapy.
    Piketty C; Selinger-Leneman H; Grabar S; Duvivier C; Bonmarchand M; Abramowitz L; Costagliola D; Mary-Krause M;
    AIDS; 2008 Jun; 22(10):1203-11. PubMed ID: 18525266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of HIV-related anal cancer remains increased despite long-term combined antiretroviral treatment: results from the french hospital database on HIV.
    Piketty C; Selinger-Leneman H; Bouvier AM; Belot A; Mary-Krause M; Duvivier C; Bonmarchand M; Abramowitz L; Costagliola D; Grabar S
    J Clin Oncol; 2012 Dec; 30(35):4360-6. PubMed ID: 23091098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV-associated Isospora belli infection: incidence and risk factors in the French Hospital Database on HIV.
    Guiguet M; Furco A; Tattevin P; Costagliola D; Molina JM;
    HIV Med; 2007 Mar; 8(2):124-30. PubMed ID: 17352769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The study to understand the natural history of HIV and AIDS in the era of effective therapy (SUN Study).
    Vellozzi C; Brooks JT; Bush TJ; Conley LJ; Henry K; Carpenter CC; Overton ET; Hammer J; Wood K; Holmberg SD;
    Am J Epidemiol; 2009 Mar; 169(5):642-52. PubMed ID: 19074775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term prognosis of HIV-infected patients with Kaposi sarcoma treated with pegylated liposomal doxorubicin.
    Martín-Carbonero L; Palacios R; Valencia E; Saballs P; Sirera G; Santos I; Baldobí F; Alegre M; Goyenechea A; Pedreira J; González del Castillo J; Martínez-Lacasa J; Ocampo A; Alsina M; Santos J; Podzamczer D; González-Lahoz J;
    Clin Infect Dis; 2008 Aug; 47(3):410-7. PubMed ID: 18582203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in bacteremia in the pre- and post-highly active antiretroviral therapy era among HIV-infected children in the US Perinatal AIDS Collaborative Transmission Study (1986-2004).
    Kapogiannis BG; Soe MM; Nesheim SR; Sullivan KM; Abrams E; Farley J; Palumbo P; Koenig LJ; Bulterys M
    Pediatrics; 2008 May; 121(5):e1229-39. PubMed ID: 18450865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anal cancer incidence rates increased in antiretroviral era. Rates increased for men and women.
    AIDS Alert; 2006 Mar; 21(3):22-3. PubMed ID: 17378064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and outcome of progressive multifocal leukoencephalopathy over 20 years of the Swiss HIV Cohort Study.
    Khanna N; Elzi L; Mueller NJ; Garzoni C; Cavassini M; Fux CA; Vernazza P; Bernasconi E; Battegay M; Hirsch HH;
    Clin Infect Dis; 2009 May; 48(10):1459-66. PubMed ID: 19348592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for osteonecrosis in HIV-infected patients: impact of treatment with combination antiretroviral therapy.
    Mary-Krause M; Billaud E; Poizot-Martin I; Simon A; Dhiver C; Dupont C; Salmon D; Roudiere L; Costagliola D;
    AIDS; 2006 Aug; 20(12):1627-35. PubMed ID: 16868444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence rate and risk factors for loss to follow-up in a French clinical cohort of HIV-infected patients from January 1985 to January 1998.
    Lebouché B; Yazdanpanah Y; Gérard Y; Sissoko D; Ajana F; Alcaraz I; Boitte P; Cadoré B; Mouton Y
    HIV Med; 2006 Apr; 7(3):140-5. PubMed ID: 16494627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for anal cancer in persons infected with HIV: a nested case-control study in the Swiss HIV Cohort Study.
    Bertisch B; Franceschi S; Lise M; Vernazza P; Keiser O; Schöni-Affolter F; Bouchardy C; Dehler S; Levi F; Jundt G; Ess S; Pawlita M; Kovari H; Wandeler G; Calmy A; Cavassini M; Stöckle M; Clifford G;
    Am J Epidemiol; 2013 Sep; 178(6):877-84. PubMed ID: 23900553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Screening and therapy of anal intraepithelial neoplasia (AIN) and anal carcinoma in patients with HIV-infection].
    Kreuter A; Reimann G; Esser S; Rasokat H; Hartmann M; Swoboda J; Conant MA; Tschachler E; Arasteh K; Altmeyer P; Brockmeyer NH
    Dtsch Med Wochenschr; 2003 Sep; 128(38):1957-62. PubMed ID: 14502448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of non-AIDS-defining cancers among HIV-1-infected individuals in France between 1997 and 2009: results from a French cohort.
    Hleyhel M; Hleyhel M; Bouvier AM; Belot A; Tattevin P; Pacanowski J; Genet P; De Castro N; Berger JL; Dupont C; Lavolé A; Pradier C; Salmon D; Simon A; Martinez V; Spano JP; Costagliola D; Grabar S;
    AIDS; 2014 Sep; 28(14):2109-18. PubMed ID: 25265077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for incident diabetes mellitus among HIV-infected patients receiving combination antiretroviral therapy in Taiwan: a case-control study.
    Lo YC; Chen MY; Sheng WH; Hsieh SM; Sun HY; Liu WC; Wu PY; Wu CH; Hung CC; Chang SC
    HIV Med; 2009 May; 10(5):302-9. PubMed ID: 19220492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of non-AIDS-defining cancers before and during the highly active antiretroviral therapy era in a cohort of human immunodeficiency virus-infected patients.
    Herida M; Mary-Krause M; Kaphan R; Cadranel J; Poizot-Martin I; Rabaud C; Plaisance N; Tissot-Dupont H; Boue F; Lang JM; Costagliola D
    J Clin Oncol; 2003 Sep; 21(18):3447-53. PubMed ID: 12972519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonoccupational postexposure prophylaxis, subsequent risk behaviour and HIV incidence in a cohort of Australian homosexual men.
    Poynten IM; Jin F; Mao L; Prestage GP; Kippax SC; Kaldor JM; Imrie J; Grulich AE
    AIDS; 2009 Jun; 23(9):1119-26. PubMed ID: 19417578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence rate and risk factors for loss to follow-up in HIV-infected patients from five French clinical centres in Northern France - January 1997 to December 2006.
    Ndiaye B; Ould-Kaci K; Salleron J; Bataille P; Bonnevie F; Choisy P; Cochonat K; Fontier C; Guerroumi H; Ajana F; Chaud P; Yazdanpanah Y
    Antivir Ther; 2009; 14(4):567-75. PubMed ID: 19578242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anal squamous intraepithelial lesions and condyloma in HIV-infected heterosexual men, homosexual men and women: prevalence and associated factors.
    Abramowitz L; Benabderrahmane D; Ravaud P; Walker F; Rioux C; Jestin C; Bouvet E; Soulé JC; Leport C; Duval X
    AIDS; 2007 Jul; 21(11):1457-65. PubMed ID: 17589192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors determining serologic response to treatment in patients with syphilis.
    González-López JJ; Guerrero ML; Luján R; Tostado SF; de Górgolas M; Requena L
    Clin Infect Dis; 2009 Nov; 49(10):1505-11. PubMed ID: 19842977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Invasive anal squamous-cell carcinoma in the HIV-positive patient: outcome in the era of highly active antiretroviral therapy.
    Wexler A; Berson AM; Goldstone SE; Waltzman R; Penzer J; Maisonet OG; McDermott B; Rescigno J
    Dis Colon Rectum; 2008 Jan; 51(1):73-81. PubMed ID: 18066626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.